The plan, which is not finalized, suggests children get fewer shots and shifts to a model telling parents to consult doctors ...

If the U.S. were to match Denmark’s selections, it would mean fewer recommended vaccines for American children. The U.S.

A lot is happening as we look ahead to 2026 from 340B developments to FDA activity, vaccines, and more. There are big shifts under way, and with them come plenty of questions. Thank you for listening ...

Six days after a senior FDA official sent a sweeping internal email claiming that COVID vaccines had caused the deaths of "at ...

The FDA has been rumored to be evaluating whether or not to place a black box warning on vaccines for COVID-19.

The Trump administration is planning to announce an overhaul to the childhood immunization schedule early next year, recommending fewer shots and aligning U.S. policy with that of Denmark. A ...

After patient deaths from interstitial lung disease in a lung cancer trial testing the antibody-drug conjugate ifinatamab deruxtecan, the FDA placed a partial hold on Daiichi Sankyo and Merck's global ...

A strict new vaccine approval process in the U.S. could dramatically slow things down for biopharma and the public, experts ...

As 2025 closes, biopharma and healthcare are learning to live on shifting ground. | Fierce reporters break down the forces that shaped biopharma and healthcare in 2025 and what lies ahead in 2026.

The Trump administration has announced sweeping policies that, if enacted, could effectively end gender-affirming care for ...

UNC's Barry Popkin joins Aaron to discuss the health impacts of "ultra-processed foods" and what policymakers should be doing ...